1. Home
  2. CTMX vs DGHI Comparison

CTMX vs DGHI Comparison

Compare CTMX & DGHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • DGHI
  • Stock Information
  • Founded
  • CTMX 2008
  • DGHI 2017
  • Country
  • CTMX United States
  • DGHI United States
  • Employees
  • CTMX N/A
  • DGHI N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • DGHI Finance: Consumer Services
  • Sector
  • CTMX Health Care
  • DGHI Finance
  • Exchange
  • CTMX Nasdaq
  • DGHI Nasdaq
  • Market Cap
  • CTMX 62.3M
  • DGHI 90.1M
  • IPO Year
  • CTMX 2015
  • DGHI N/A
  • Fundamental
  • Price
  • CTMX $0.80
  • DGHI $2.63
  • Analyst Decision
  • CTMX Buy
  • DGHI Strong Buy
  • Analyst Count
  • CTMX 6
  • DGHI 1
  • Target Price
  • CTMX $5.77
  • DGHI $2.50
  • AVG Volume (30 Days)
  • CTMX 731.5K
  • DGHI 1.0M
  • Earning Date
  • CTMX 03-10-2025
  • DGHI 04-02-2025
  • Dividend Yield
  • CTMX N/A
  • DGHI N/A
  • EPS Growth
  • CTMX N/A
  • DGHI N/A
  • EPS
  • CTMX 0.16
  • DGHI N/A
  • Revenue
  • CTMX $126,617,000.00
  • DGHI $42,146,057.00
  • Revenue This Year
  • CTMX $22.55
  • DGHI N/A
  • Revenue Next Year
  • CTMX N/A
  • DGHI N/A
  • P/E Ratio
  • CTMX $4.93
  • DGHI N/A
  • Revenue Growth
  • CTMX 33.66
  • DGHI 100.56
  • 52 Week Low
  • CTMX $0.75
  • DGHI $0.84
  • 52 Week High
  • CTMX $5.85
  • DGHI $3.77
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 41.61
  • DGHI 49.56
  • Support Level
  • CTMX $0.75
  • DGHI $2.81
  • Resistance Level
  • CTMX $0.98
  • DGHI $3.48
  • Average True Range (ATR)
  • CTMX 0.06
  • DGHI 0.46
  • MACD
  • CTMX 0.00
  • DGHI -0.06
  • Stochastic Oscillator
  • CTMX 20.13
  • DGHI 10.24

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About DGHI Digihost Technology Inc. Common Subordinate Voting Shares

Digihost Technology Inc is a blockchain company focused on Bitcoin mining. The company's mining facility is located in Buffalo, New York, and is equipped with an 18.7 MVA 115,000-kilovolt ampere outdoor substation with an option to increase the power output to 42MVA.

Share on Social Networks: